Modeling Alzheimer's disease with iPSC-derived brain cells

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• Alzheimer's disease (AD) is a leading cause of neurodegeneration with no cure.
• Many AD therapeutics effective in animal models fail in human clinical trials.
• Novel approaches are needed to understand AD pathophysiology.

Purpose of the Study:

• To highlight the potential of human induced pluripotent stem cell (iPSC) technologies in Alzheimer's disease research.
• To discuss the application of iPSC-derived cells and co-culture systems in modeling AD.
• To emphasize the role of iPSC-based systems and genome editing in identifying AD risk factors.

Main Methods:

• Differentiation of iPSCs into various brain cell types.
• Development of complex iPSC co-culture systems.
• Utilizing iPSC-derived cells to recapitulate AD cellular dysfunctions in vitro.
• Application of genome editing tools with iPSC technology.

Main Results:

• iPSC-derived cells can model key cellular functions perturbed in Alzheimer's disease.
• Co-culture platforms provide insights into inter-neuronal interactions during neurodegeneration.
• iPSC technology combined with genome editing aids in understanding AD genetic risk factors.

Conclusions:

• Human iPSC technology is revolutionizing preclinical research for neurodegenerative diseases like Alzheimer's.
• iPSC-based models offer a promising avenue for dissecting AD complexity and developing effective therapeutics.
• Further development of iPSC technologies holds significant potential for combating Alzheimer's disease.